Boryung Incorporation won a nullity suit of patent of a kinase inhibitor, ‘Gleevec’.
(Yakup shinmoon)
Boryung Inc. (President, Tae-hong Choi) won a nullity suit with Novartis of patent of a kinase inhibitor, ‘Gleevec’ (the name of ingredient is Imatinib met...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
